Also, quite a few effectively established adverse prognostic markers, which includes U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their detrimental result in individuals dealt with with VO. The only real aspect that remained predictive of the shorter progression-cost-free survival in this cohort of individuals was TP53 aberrations.112 Fin